Financial results - MD PHARMABEST S.R.L.

Financial Summary - Md Pharmabest S.r.l.
Unique identification code: 21515832
Registration number: J40/6944/2007
Nace: 4646
Sales - Ron
43.927
Net Profit - Ron
-24.335
Employees
1
Open Account
Company Md Pharmabest S.r.l. with Fiscal Code 21515832 recorded a turnover of 2024 of 43.927, with a net profit of -24.335 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Md Pharmabest S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 0 0 4.528 19.455 129.145 126.159 43.927
Total Income - EUR - - - 0 0 4.528 19.459 129.856 125.182 45.935
Total Expenses - EUR - - - 51 63 0 13.867 71.635 72.988 69.810
Gross Profit/Loss - EUR - - - -51 -63 4.528 5.593 58.221 52.194 -23.876
Net Profit/Loss - EUR - - - -51 -63 4.392 5.009 56.924 50.946 -24.335
Employees - - - 0 0 0 1 2 2 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -65.0%, from 126.159 euro in the year 2023, to 43.927 euro in 2024. The Net Profit decreased by -50.661 euro, from 50.946 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Md Pharmabest S.r.l.

Rating financiar

Financial Rating -
MD PHARMABEST S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Md Pharmabest S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Md Pharmabest S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Md Pharmabest S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Md Pharmabest S.r.l. - CUI 21515832

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 0 0 0 800 4.551 8.556 35.302
Current Assets - - - 0 45 4.571 14.812 67.023 84.830 29.183
Inventories - - - 0 0 0 3.718 6.076 7.246 7.789
Receivables - - - 0 0 3.928 5.907 46.636 73.089 16.310
Cash - - - 0 45 643 5.186 14.311 4.495 5.083
Shareholders Funds - - - -51 -71 4.322 9.235 56.972 75.664 31.086
Social Capital - - - 0 42 41 40 41 40 40
Debts - - - 51 116 250 6.377 14.602 17.722 33.399
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4711
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 29.183 euro in 2024 which includes Inventories of 7.789 euro, Receivables of 16.310 euro and cash availability of 5.083 euro.
The company's Equity was valued at 31.086 euro, while total Liabilities amounted to 33.399 euro. Equity decreased by -44.154 euro, from 75.664 euro in 2023, to 31.086 in 2024.

Risk Reports Prices

Reviews - Md Pharmabest S.r.l.

Comments - Md Pharmabest S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.